SYSTEMIC ACCESS OF RNAI TO TARGET TISSUES Trademark

Trademark Overview

On Friday, August 13, 2010, a trademark application was filed for SYSTEMIC ACCESS OF RNAI TO TARGET TISSUES with the United States Patent and Trademark Office. The USPTO has given the SYSTEMIC ACCESS OF RNAI TO TARGET TISSUES trademark a serial number of 85107157. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 11, 2014. This trademark is owned by PhaseRx, Inc.. The SYSTEMIC ACCESS OF RNAI TO TARGET TISSUES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations, namely, polymeric delivery technology and formulations in the form of powders or liquid solutions for delivery of macromolecular therapeutics for use in human and veterinary medicine

Medical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics; product research and development in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics
systemic access of rnai to target tissues

General Information

Serial Number85107157
Word MarkSYSTEMIC ACCESS OF RNAI TO TARGET TISSUES
Filing DateFriday, August 13, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 11, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, polymeric delivery technology and formulations in the form of powders or liquid solutions for delivery of macromolecular therapeutics for use in human and veterinary medicine
Goods and ServicesMedical and scientific research in the fields of pharmaceuticals, biologics, drug delivery and medical therapeutics; product research and development in the fields of pharmaceutical formulations of macromolecules, macromolecular pharmaceutical products, macromolecular therapeutics, and delivery of macromolecular therapeutics

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 18, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 18, 2010
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePhaseRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119
Party NamePhaseRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98119

Trademark Events

Event DateEvent Description
Monday, August 11, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 11, 2014ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 22, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 21, 2014EXTENSION 4 GRANTED
Tuesday, December 24, 2013EXTENSION 4 FILED
Tuesday, December 24, 2013TEAS EXTENSION RECEIVED
Monday, December 23, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2013EXTENSION 3 GRANTED
Monday, July 1, 2013EXTENSION 3 FILED
Monday, July 1, 2013TEAS EXTENSION RECEIVED
Wednesday, January 16, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 15, 2013EXTENSION 2 GRANTED
Thursday, December 20, 2012EXTENSION 2 FILED
Thursday, December 20, 2012TEAS EXTENSION RECEIVED
Thursday, December 20, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 19, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 18, 2012EXTENSION 1 GRANTED
Tuesday, June 19, 2012EXTENSION 1 FILED
Friday, July 13, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, June 19, 2012TEAS EXTENSION RECEIVED
Tuesday, January 10, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2011PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2011NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 13, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, October 8, 2011ASSIGNED TO LIE
Thursday, September 22, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 7, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 7, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 7, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 15, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 15, 2011NON-FINAL ACTION E-MAILED
Tuesday, March 15, 2011NON-FINAL ACTION WRITTEN
Monday, February 21, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 21, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 21, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, December 5, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, December 5, 2010NON-FINAL ACTION E-MAILED
Sunday, December 5, 2010NON-FINAL ACTION WRITTEN
Tuesday, November 30, 2010ASSIGNED TO EXAMINER
Thursday, August 19, 2010NOTICE OF PSEUDO MARK MAILED
Wednesday, August 18, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, August 17, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

tissues target rnai access systemic macromolecular therapeutics delivery pharmaceutical medical formulations research fields scientific drug